 | • レポートコード：MRC2-11QY13618 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はエイズ（HIV）関連がんのグローバル市場について調査・分析したレポートです。種類別（カポジ肉腫（KS）、非ホジキンリンパ腫（NHL）、子宮頸がん）市場規模、用途別（男性、女性）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別エイズ（HIV）関連がんの競争状況、市場シェア ・世界のエイズ（HIV）関連がん市場：種類別市場規模 2015年-2020年（カポジ肉腫（KS）、非ホジキンリンパ腫（NHL）、子宮頸がん） ・世界のエイズ（HIV）関連がん市場：種類別市場規模予測 2021年-2026年（カポジ肉腫（KS）、非ホジキンリンパ腫（NHL）、子宮頸がん） ・世界のエイズ（HIV）関連がん市場：用途別市場規模 2015年-2020年（男性、女性） ・世界のエイズ（HIV）関連がん市場：用途別市場規模予測 2021年-2026年（男性、女性） ・北米のエイズ（HIV）関連がん市場分析：米国、カナダ ・ヨーロッパのエイズ（HIV）関連がん市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのエイズ（HIV）関連がん市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のエイズ（HIV）関連がん市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのエイズ（HIV）関連がん市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol Myers Squibb Company、Takeda Pharmaceuticals Company、Gilead Sciences、F.Hoffmann-La Roche、Pfizer、AbbVie ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The cancers occurring most commonly in the patients infected with human immunodeficiency virus (HIV) are referred to as AIDS related cancers. Kaposi sarcoma, cervical cancer and non-Hodgkin lymphoma are some of the most common AIDS related cancers. Cancers of throat, lungs, colon, skin, rectum, mouth and liver constitute less common type of AIDS related cancers. HIV patients are considered to be at a high risk of developing cancers. The exact link of AIDS and cancers is unknown but majorly depends on the weakened immune system.
The major factors favoring the growth of market are increasing incidence of HIV infections in conjunction with the cancers across the globe. In addition, increasing participation of key market players towards developing novel treatment approaches along with elevated awareness levels will further propel the market growth. On the other hand, factors such as difficulties in deciphering the exact cause of AIDS related cancers and huge investments in clinical trials are some of the factors that might restrain the market growth.
Market Analysis and Insights: Global AIDS Related Cancer Market
The global AIDS Related Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global AIDS Related Cancer Scope and Market Size
AIDS Related Cancer market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global AIDS Related Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bristol Myers Squibb Company
Takeda Pharmaceuticals Company
Gilead Sciences
F.Hoffmann-La Roche
Pfizer
AbbVie
…
Market segment by Type, the product can be split into
Kaposi Sarcoma (KS)
Non-Hodgkin lymphoma (NHL)
Cervical Cancer
Market segment by Application, split into
Male
Female
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by AIDS Related Cancer Revenue
1.4 Market by Type
1.4.1 Global AIDS Related Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Kaposi Sarcoma (KS)
1.4.3 Non-Hodgkin lymphoma (NHL)
1.4.4 Cervical Cancer
1.5 Market by Application
1.5.1 Global AIDS Related Cancer Market Share by Application: 2020 VS 2026
1.5.2 Male
1.5.3 Female
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global AIDS Related Cancer Market Perspective (2015-2026)
2.2 Global AIDS Related Cancer Growth Trends by Regions
2.2.1 AIDS Related Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 AIDS Related Cancer Historic Market Share by Regions (2015-2020)
2.2.3 AIDS Related Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 AIDS Related Cancer Market Growth Strategy
2.3.6 Primary Interviews with Key AIDS Related Cancer Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top AIDS Related Cancer Players by Market Size
3.1.1 Global Top AIDS Related Cancer Players by Revenue (2015-2020)
3.1.2 Global AIDS Related Cancer Revenue Market Share by Players (2015-2020)
3.1.3 Global AIDS Related Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global AIDS Related Cancer Market Concentration Ratio
3.2.1 Global AIDS Related Cancer Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by AIDS Related Cancer Revenue in 2019
3.3 AIDS Related Cancer Key Players Head office and Area Served
3.4 Key Players AIDS Related Cancer Product Solution and Service
3.5 Date of Enter into AIDS Related Cancer Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global AIDS Related Cancer Historic Market Size by Type (2015-2020)
4.2 Global AIDS Related Cancer Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global AIDS Related Cancer Market Size by Application (2015-2020)
5.2 Global AIDS Related Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America AIDS Related Cancer Market Size (2015-2020)
6.2 AIDS Related Cancer Key Players in North America (2019-2020)
6.3 North America AIDS Related Cancer Market Size by Type (2015-2020)
6.4 North America AIDS Related Cancer Market Size by Application (2015-2020)
7 Europe
7.1 Europe AIDS Related Cancer Market Size (2015-2020)
7.2 AIDS Related Cancer Key Players in Europe (2019-2020)
7.3 Europe AIDS Related Cancer Market Size by Type (2015-2020)
7.4 Europe AIDS Related Cancer Market Size by Application (2015-2020)
8 China
8.1 China AIDS Related Cancer Market Size (2015-2020)
8.2 AIDS Related Cancer Key Players in China (2019-2020)
8.3 China AIDS Related Cancer Market Size by Type (2015-2020)
8.4 China AIDS Related Cancer Market Size by Application (2015-2020)
9 Japan
9.1 Japan AIDS Related Cancer Market Size (2015-2020)
9.2 AIDS Related Cancer Key Players in Japan (2019-2020)
9.3 Japan AIDS Related Cancer Market Size by Type (2015-2020)
9.4 Japan AIDS Related Cancer Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia AIDS Related Cancer Market Size (2015-2020)
10.2 AIDS Related Cancer Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia AIDS Related Cancer Market Size by Type (2015-2020)
10.4 Southeast Asia AIDS Related Cancer Market Size by Application (2015-2020)
11 India
11.1 India AIDS Related Cancer Market Size (2015-2020)
11.2 AIDS Related Cancer Key Players in India (2019-2020)
11.3 India AIDS Related Cancer Market Size by Type (2015-2020)
11.4 India AIDS Related Cancer Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America AIDS Related Cancer Market Size (2015-2020)
12.2 AIDS Related Cancer Key Players in Central & South America (2019-2020)
12.3 Central & South America AIDS Related Cancer Market Size by Type (2015-2020)
12.4 Central & South America AIDS Related Cancer Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol Myers Squibb Company
13.1.1 Bristol Myers Squibb Company Company Details
13.1.2 Bristol Myers Squibb Company Business Overview
13.1.3 Bristol Myers Squibb Company AIDS Related Cancer Introduction
13.1.4 Bristol Myers Squibb Company Revenue in AIDS Related Cancer Business (2015-2020))
13.1.5 Bristol Myers Squibb Company Recent Development
13.2 Takeda Pharmaceuticals Company
13.2.1 Takeda Pharmaceuticals Company Company Details
13.2.2 Takeda Pharmaceuticals Company Business Overview
13.2.3 Takeda Pharmaceuticals Company AIDS Related Cancer Introduction
13.2.4 Takeda Pharmaceuticals Company Revenue in AIDS Related Cancer Business (2015-2020)
13.2.5 Takeda Pharmaceuticals Company Recent Development
13.3 Gilead Sciences
13.3.1 Gilead Sciences Company Details
13.3.2 Gilead Sciences Business Overview
13.3.3 Gilead Sciences AIDS Related Cancer Introduction
13.3.4 Gilead Sciences Revenue in AIDS Related Cancer Business (2015-2020)
13.3.5 Gilead Sciences Recent Development
13.4 F.Hoffmann-La Roche
13.4.1 F.Hoffmann-La Roche Company Details
13.4.2 F.Hoffmann-La Roche Business Overview
13.4.3 F.Hoffmann-La Roche AIDS Related Cancer Introduction
13.4.4 F.Hoffmann-La Roche Revenue in AIDS Related Cancer Business (2015-2020)
13.4.5 F.Hoffmann-La Roche Recent Development
13.5 Pfizer
13.5.1 Pfizer Company Details
13.5.2 Pfizer Business Overview
13.5.3 Pfizer AIDS Related Cancer Introduction
13.5.4 Pfizer Revenue in AIDS Related Cancer Business (2015-2020)
13.5.5 Pfizer Recent Development
13.6 AbbVie
13.6.1 AbbVie Company Details
13.6.2 AbbVie Business Overview
13.6.3 AbbVie AIDS Related Cancer Introduction
13.6.4 AbbVie Revenue in AIDS Related Cancer Business (2015-2020)
13.6.5 AbbVie Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. AIDS Related Cancer Key Market Segments
Table 2. Key Players Covered: Ranking by AIDS Related Cancer Revenue
Table 3. Ranking of Global Top AIDS Related Cancer Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global AIDS Related Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Kaposi Sarcoma (KS)
Table 6. Key Players of Non-Hodgkin lymphoma (NHL)
Table 7. Key Players of Cervical Cancer
Table 8. Global AIDS Related Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global AIDS Related Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global AIDS Related Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global AIDS Related Cancer Market Share by Regions (2015-2020)
Table 12. Global AIDS Related Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global AIDS Related Cancer Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. AIDS Related Cancer Market Growth Strategy
Table 18. Main Points Interviewed from Key AIDS Related Cancer Players
Table 19. Global AIDS Related Cancer Revenue by Players (2015-2020) (Million US$)
Table 20. Global AIDS Related Cancer Market Share by Players (2015-2020)
Table 21. Global Top AIDS Related Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in AIDS Related Cancer as of 2019)
Table 22. Global AIDS Related Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players AIDS Related Cancer Product Solution and Service
Table 25. Date of Enter into AIDS Related Cancer Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global AIDS Related Cancer Market Size by Type (2015-2020) (Million US$)
Table 28. Global AIDS Related Cancer Market Size Share by Type (2015-2020)
Table 29. Global AIDS Related Cancer Revenue Market Share by Type (2021-2026)
Table 30. Global AIDS Related Cancer Market Size Share by Application (2015-2020)
Table 31. Global AIDS Related Cancer Market Size by Application (2015-2020) (Million US$)
Table 32. Global AIDS Related Cancer Market Size Share by Application (2021-2026)
Table 33. North America Key Players AIDS Related Cancer Revenue (2019-2020) (Million US$)
Table 34. North America Key Players AIDS Related Cancer Market Share (2019-2020)
Table 35. North America AIDS Related Cancer Market Size by Type (2015-2020) (Million US$)
Table 36. North America AIDS Related Cancer Market Share by Type (2015-2020)
Table 37. North America AIDS Related Cancer Market Size by Application (2015-2020) (Million US$)
Table 38. North America AIDS Related Cancer Market Share by Application (2015-2020)
Table 39. Europe Key Players AIDS Related Cancer Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players AIDS Related Cancer Market Share (2019-2020)
Table 41. Europe AIDS Related Cancer Market Size by Type (2015-2020) (Million US$)
Table 42. Europe AIDS Related Cancer Market Share by Type (2015-2020)
Table 43. Europe AIDS Related Cancer Market Size by Application (2015-2020) (Million US$)
Table 44. Europe AIDS Related Cancer Market Share by Application (2015-2020)
Table 45. China Key Players AIDS Related Cancer Revenue (2019-2020) (Million US$)
Table 46. China Key Players AIDS Related Cancer Market Share (2019-2020)
Table 47. China AIDS Related Cancer Market Size by Type (2015-2020) (Million US$)
Table 48. China AIDS Related Cancer Market Share by Type (2015-2020)
Table 49. China AIDS Related Cancer Market Size by Application (2015-2020) (Million US$)
Table 50. China AIDS Related Cancer Market Share by Application (2015-2020)
Table 51. Japan Key Players AIDS Related Cancer Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players AIDS Related Cancer Market Share (2019-2020)
Table 53. Japan AIDS Related Cancer Market Size by Type (2015-2020) (Million US$)
Table 54. Japan AIDS Related Cancer Market Share by Type (2015-2020)
Table 55. Japan AIDS Related Cancer Market Size by Application (2015-2020) (Million US$)
Table 56. Japan AIDS Related Cancer Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players AIDS Related Cancer Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players AIDS Related Cancer Market Share (2019-2020)
Table 59. Southeast Asia AIDS Related Cancer Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia AIDS Related Cancer Market Share by Type (2015-2020)
Table 61. Southeast Asia AIDS Related Cancer Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia AIDS Related Cancer Market Share by Application (2015-2020)
Table 63. India Key Players AIDS Related Cancer Revenue (2019-2020) (Million US$)
Table 64. India Key Players AIDS Related Cancer Market Share (2019-2020)
Table 65. India AIDS Related Cancer Market Size by Type (2015-2020) (Million US$)
Table 66. India AIDS Related Cancer Market Share by Type (2015-2020)
Table 67. India AIDS Related Cancer Market Size by Application (2015-2020) (Million US$)
Table 68. India AIDS Related Cancer Market Share by Application (2015-2020)
Table 69. Central & South America Key Players AIDS Related Cancer Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players AIDS Related Cancer Market Share (2019-2020)
Table 71. Central & South America AIDS Related Cancer Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America AIDS Related Cancer Market Share by Type (2015-2020)
Table 73. Central & South America AIDS Related Cancer Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America AIDS Related Cancer Market Share by Application (2015-2020)
Table 75. Bristol Myers Squibb Company Company Details
Table 76. Bristol Myers Squibb Company Business Overview
Table 77. Bristol Myers Squibb Company Product
Table 78. Bristol Myers Squibb Company Revenue in AIDS Related Cancer Business (2015-2020) (Million US$)
Table 79. Bristol Myers Squibb Company Recent Development
Table 80. Takeda Pharmaceuticals Company Company Details
Table 81. Takeda Pharmaceuticals Company Business Overview
Table 82. Takeda Pharmaceuticals Company Product
Table 83. Takeda Pharmaceuticals Company Revenue in AIDS Related Cancer Business (2015-2020) (Million US$)
Table 84. Takeda Pharmaceuticals Company Recent Development
Table 85. Gilead Sciences Company Details
Table 86. Gilead Sciences Business Overview
Table 87. Gilead Sciences Product
Table 88. Gilead Sciences Revenue in AIDS Related Cancer Business (2015-2020) (Million US$)
Table 89. Gilead Sciences Recent Development
Table 90. F.Hoffmann-La Roche Company Details
Table 91. F.Hoffmann-La Roche Business Overview
Table 92. F.Hoffmann-La Roche Product
Table 93. F.Hoffmann-La Roche Revenue in AIDS Related Cancer Business (2015-2020) (Million US$)
Table 94. F.Hoffmann-La Roche Recent Development
Table 95. Pfizer Company Details
Table 96. Pfizer Business Overview
Table 97. Pfizer Product
Table 98. Pfizer Revenue in AIDS Related Cancer Business (2015-2020) (Million US$)
Table 99. Pfizer Recent Development
Table 100. AbbVie Company Details
Table 101. AbbVie Business Overview
Table 102. AbbVie Product
Table 103. AbbVie Revenue in AIDS Related Cancer Business (2015-2020) (Million US$)
Table 104. AbbVie Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global AIDS Related Cancer Market Share by Type: 2020 VS 2026
Figure 2. Kaposi Sarcoma (KS) Features
Figure 3. Non-Hodgkin lymphoma (NHL) Features
Figure 4. Cervical Cancer Features
Figure 5. Global AIDS Related Cancer Market Share by Application: 2020 VS 2026
Figure 6. Male Case Studies
Figure 7. Female Case Studies
Figure 8. AIDS Related Cancer Report Years Considered
Figure 9. Global AIDS Related Cancer Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global AIDS Related Cancer Market Share by Regions: 2020 VS 2026
Figure 11. Global AIDS Related Cancer Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global AIDS Related Cancer Market Share by Players in 2019
Figure 14. Global Top AIDS Related Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in AIDS Related Cancer as of 2019
Figure 15. The Top 10 and 5 Players Market Share by AIDS Related Cancer Revenue in 2019
Figure 16. North America AIDS Related Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe AIDS Related Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China AIDS Related Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan AIDS Related Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia AIDS Related Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India AIDS Related Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America AIDS Related Cancer Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
子宮頸がんスクリーニングの世界市場（～2026年） Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops. Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. Th…- 子宮頸がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Diagnostic Test Market The global Cervical Cancer Diagnostic Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
- 子宮頸がん治療法・診断の世界市場（～2026年） Therapies and Diagnostics for Cervical Cancer refers to a series of methods and medical devices that can be used for the diagnosis and treatment of cervical cancer. The factors that are driving the cervical cancer market are HPV infection, women having many sexual partners, women getting sexually ac…
- 子宮頸がんワクチンの世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Vaccine Market The global Cervical Cancer Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cervical Cancer Vaccine Scope and Market Size Cervical Cancer Vacci…
- カポジ肉腫（KS）の世界市場（～2026年） Kaposi's sarcoma (KS) is a type of cancer that can form masses in the skin, lymph nodes, or other organs. The skin lesions are usually purplein color. They can occur singularly, in a limited area, or be widespread. It may worsen either gradually or quickly. Lesions may be flat or raised. Four sub-ty…